Back to today’s briefing

Story perspectives

Pharma Giants Urge U.K. to Rethink Drug Cost Controls

3/20/2025

44 6

Summary

Story summary

Major pharmaceutical giants like AstraZeneca and Pfizer are calling on the U.K. government to rethink a drug cost control program that restricts NHS spending on branded medications. They advocate for a system that aligns with NHS funding growth and introduces risk-sharing strategies. The recent rebate hike to 22.9% jeopardizes vital investment and innovation in the U.K.'s life sciences landscape.

1 of 1

Story summary

Major pharmaceutical giants like AstraZeneca and Pfizer are calling on the U.K. government to rethink a drug cost control program that restricts NHS spending on branded medications. They advocate for a system that aligns with NHS funding growth and introduces risk-sharing strategies. The recent rebate hike to 22.9% jeopardizes vital investment and innovation in the U.K.'s life sciences landscape.